BioClin Therapeutics Appoints Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, M.D., as Chief Medical Officer

BioClin Therapeutics, Inc.(BioClin), announced today the appointments of Graeme Currie, Ph.D., as Chief Operating Officer and Esteban (Steve) Abella, M.D., as Chief Medical Officer.

Sanifit announces the appointment of Cris Calsada as Chief Financial Officer

Laboratoris Sanifit S.L., a clinical-stage biopharmaceutical company focused on treatments for calcification disorders, today announced the appointment of Cris Calsada as Chief Financial Officer.

STAT-Dx announces CE-IVD mark completion for DiagCORE® System and Respiratory Panel

Takeda announces its intention to acquire TiGenix

TiGenix NV has announced its intention to launch a voluntary conditional takeover bid on TiGenix.

Kala pharmaceuticals announces new drug application for inveltystm (kpi-121 1%) has been accepted for review by the u.s. Food and drug administration

Minoryx Therapeutics announces the dosing of first patient in ADVANCE, a phase 2/3 clinical study of MIN-102 in patients with adrenomyeloneuropathy (AMN)

Minoryx Therapeutics, today announces the initiation of treatment of the first two patients in the ADVANCE trial, a pivotal phase 2/3 clinical trial of MIN-102 for the treatment of adrenomyeloneuropathy (AMN).

Aura Biosciences Completes $30 Million Series C Financing

The company plans to use proceeds from this round of financing to expand infrastructure supporting ongoing clinical development.

Sanifit Announces Last Patient Last Visit completed in Clinical Trial of SNF472 in Patients with Calciphylaxis

Laboratoris Sanifit S.L., announced today that the Last Patient's Last Visit (LPLV) occurred in the Phase II study of SNF472, its lead candidate for the treatment of the orphan disease calciphylaxis (calcific uraemic arteriolopathy, CUA) for which there is currently no approved agent.

Sanifit appoints Alexander M. Gold, M.D., F.A.C.C. as Chief Medical Officer and President of its US subsidiary

Laboratoris Sanifit S.L., today announces the appointment of Alexander M. Gold, M.D., F.A.C.C. as Chief Medical Officer and President of its US subsidiary Sanifit Inc.

Aura Biosciences Strengthens Leadership Team with Addition of Cadmus Rich, M.D., as Chief Medical Officer

Aura Biosciences, today announced that Cadmus Rich, M.D., has joined the company’s leadership team as Chief Medical Officer.